Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
OPTN | US
-0.03
-2.80%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
30/08/2024
1.04
1.07
1.07
1.03
OptiNose Inc. a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear nose throat and allergy specialists in the United States. The company offers XHANCE a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail a powder EDS device. OptiNose Inc. has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Orexia Therapeutics to develop manufacture import and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment diagnosis or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. The company was founded in 2000 and is headquartered in Yardley Pennsylvania.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
56.9%1 month
64.6%3 months
64.7%6 months
79.9%-
-
24.26
-2.94
0.96
-4.33
2.38
-
-18.45M
156.81M
156.81M
-
-31.96
-
5.30
-1.05K
9.83
5.86
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.19
Range1M
0.30
Range3M
0.49
Rel. volume
0.32
Price X volume
170.04K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Galectin Therapeutics Inc | GALT | Drug Manufacturers-Specialty & Generic | 2.695 | 167.84M | -1.64% | n/a | -113.78% |
CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 1.94 | 135.57M | 3.19% | n/a | 1.07% |
LFCR | LFCR | Drug Manufacturers-Specialty & Generic | 4.38 | 135.21M | 14.81% | 19.08 | 241.85% |
Zomedica Pharmaceuticals Corp | ZOM | Drug Manufacturers-Specialty & Generic | 0.1289 | 128.64M | 1.90% | n/a | 1.10% |
Aceto Corporation | ACET | Drug Manufacturers-Specialty & Generic | 1.46 | 120.31M | -1.35% | n/a | 8.14% |
Veru Inc | VERU | Drug Manufacturers-Specialty & Generic | 0.8184 | 119.80M | 0.42% | n/a | 36.36% |
Assertio Therapeutics Inc | ASRT | Drug Manufacturers-Specialty & Generic | 1.18 | 112.50M | 1.72% | n/a | 30.76% |
INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 2.27 | 103.45M | 1.79% | n/a | 41.98% |
Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 0.7602 | 94.78M | -1.38% | n/a | -148.05% |
Benitec Biopharma Limited | BNTC | Drug Manufacturers-Specialty & Generic | 9.245 | 93.25M | 2.15% | n/a | 3.08% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 53.7 | 152.52M | -0.37% | 8.22 | 71.47% |
Unifi Inc | UFI | Textile Manufacturing | 6.83 | 124.66M | -2.84% | n/a | 52.56% |
Culp Inc | CULP | Textile Manufacturing | 5.02 | 62.60M | 0.20% | n/a | 11.29% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 3.68 | 39.85M | -1.12% | n/a | 54.96% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.34 | 28.51M | 13.04% | n/a | 16.03% |
ILAG | ILAG | Building Products & Equipment | 1.25 | 22.57M | 6.84% | n/a | 5.48% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.76 | 11.69M | 7.80% | n/a | 422.08% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2495 | 3.93M | 5.94% | n/a | 0.97% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.391 | 3.72M | -6.28% | n/a | 19.98% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.45 | 3.70M | 13.28% | n/a | 9.62% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -4.33 | - | Cheaper |
Ent. to Revenue | 2.38 | - | Cheaper |
PE Ratio | - | 28.13 | - |
Price to Book | 24.26 | 11.07 | Expensive |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 64.71 | - | Par |
Debt to Equity | -2.94 | -0.91 | Cheaper |
Debt to Assets | 0.96 | 0.45 | Expensive |
Market Cap | 156.81M | - | Emerging |